Zacks Research Predicts Lower Earnings for DENTSPLY SIRONA

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) - Stock analysts at Zacks Research lowered their Q3 2025 earnings per share (EPS) estimates for DENTSPLY SIRONA in a research note issued to investors on Thursday, May 29th. Zacks Research analyst I. Bandyopadhyay now anticipates that the medical instruments supplier will post earnings per share of $0.46 for the quarter, down from their prior estimate of $0.49. The consensus estimate for DENTSPLY SIRONA's current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA's Q1 2027 earnings at $0.39 EPS and FY2027 earnings at $2.23 EPS.

XRAY has been the subject of a number of other reports. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a research report on Friday, February 28th. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 target price for the company. in a research report on Tuesday, April 15th. Wall Street Zen raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Piper Sandler decreased their target price on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating for the company in a research report on Wednesday, April 30th. Finally, Barrington Research lifted their target price on shares of DENTSPLY SIRONA from $20.00 to $21.00 and gave the stock an "outperform" rating in a research note on Monday, May 12th. Eleven research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $20.36.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock traded down $0.36 during mid-day trading on Monday, reaching $15.62. 1,999,347 shares of the company's stock were exchanged, compared to its average volume of 2,962,926. The business's fifty day simple moving average is $14.52 and its 200 day simple moving average is $17.01. The firm has a market capitalization of $3.11 billion, a PE ratio of -7.55, a P/E/G ratio of 1.80 and a beta of 0.92. DENTSPLY SIRONA has a one year low of $12.16 and a one year high of $28.25. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.29 by $0.14. The business had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA's quarterly revenue was down 7.8% compared to the same quarter last year. During the same period last year, the company posted $0.42 earnings per share.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.10%. DENTSPLY SIRONA's payout ratio is -14.10%.

Institutional Trading of DENTSPLY SIRONA

A number of hedge funds and other institutional investors have recently made changes to their positions in XRAY. AQR Capital Management LLC raised its stake in shares of DENTSPLY SIRONA by 119.4% during the 1st quarter. AQR Capital Management LLC now owns 6,346,685 shares of the medical instruments supplier's stock valued at $93,423,000 after purchasing an additional 3,453,662 shares during the period. Nuance Investments LLC increased its stake in DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Norges Bank bought a new position in DENTSPLY SIRONA in the 4th quarter worth about $45,730,000. Goldman Sachs Group Inc. increased its stake in DENTSPLY SIRONA by 827.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier's stock worth $36,378,000 after acquiring an additional 2,172,343 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in DENTSPLY SIRONA by 18.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.